-
公开(公告)号:AU2018200326A1
公开(公告)日:2018-02-01
申请号:AU2018200326
申请日:2018-01-15
Applicant: CODA THERAPEUTICS INC
Inventor: DUFT BRADFORD J , BECKER DAVID L , GREEN COLIN R
IPC: A61K38/18 , A61K31/711
Abstract: IMPROVED METHODS AND COMPOSITIONS FOR WOUND HEALING Methods and compositions comprising combinations of one or more anti-connexin agents and one or more other agents useful for the promotion and/or improvement of wound healing and/or tissue repair.
-
公开(公告)号:AU2016216611A1
公开(公告)日:2016-09-01
申请号:AU2016216611
申请日:2016-08-17
Applicant: CODA THERAPEUTICS INC
Inventor: GREEN COLIN , DUFT BRADFORD J
IPC: C12N15/113 , A61P25/00
Abstract: TREATMENT OF PAIN WITH GAP JUNCTION MODULATION The present invention relates to delivery, including transdermal delivery, of a therapeutically effective amount of a compound useful for modulating gap junction formation and function, including an oligonucleotide for reducing gap junction formation and function, and methods and compositions for treating a subject suffering from pain associated with a disease, disorder or condition and associated with pain, including but not limited to muscle pain, ligament pain, tendon pain, joint pain and post-operative pain.
-
公开(公告)号:CA2940648A1
公开(公告)日:2015-09-03
申请号:CA2940648
申请日:2015-02-25
Applicant: CODA THERAPEUTICS INC
Inventor: BANNAN SCOTT , MATSUOKA GROVE , DUFT BRADFORD , PHILLIPS ANTHONY , EISENBUD DAVID
Abstract: Connexin protein modulation methods and compositions are provided for the healing of resistant lesions, including lesions on subjects with multiple venous leg ulcers or multiple diabetic foot ulcers, and other responder subjects. Also provided are kits and articles of manufacture comprising a connexin protein modulating agent, for example, a connexin 43 modulating agent for use in the healing of resistant lesions.
-
公开(公告)号:AU2015201309A1
公开(公告)日:2015-04-02
申请号:AU2015201309
申请日:2015-03-12
Applicant: CODA THERAPEUTICS INC
Inventor: DUFT BRADFORD J , BECKER DAVID L , GREEN COLIN R
IPC: A61K31/7088 , A61K48/00 , A61L15/00 , A61P17/02 , A61P43/00 , C12N15/113
Abstract: Treatment of Fibrotic Conditions Abstract Treatment of fibrosis and fibrotic diseases, disorders, and conditions, and associated methods, compositions, formulations and articles.
-
公开(公告)号:AT533515T
公开(公告)日:2011-12-15
申请号:AT05016736
申请日:2000-01-27
Applicant: CODA THERAPEUTICS INC
Inventor: BECKER DAVID DR , GREEN COLIN R DR
-
公开(公告)号:AU2008343843A1
公开(公告)日:2009-07-09
申请号:AU2008343843
申请日:2008-12-22
Applicant: CODA THERAPEUTICS INC
Inventor: BECKER DAVID L , GREEN COLIN R , DUFT BRADFORD J
-
57.
公开(公告)号:AU2008343758A1
公开(公告)日:2009-07-09
申请号:AU2008343758
申请日:2008-12-22
Applicant: CODA THERAPEUTICS INC
Inventor: GREEN COLIN R , DUFT BRADFORD J , BECKER DAVID L
IPC: A61K31/7088 , A61P17/02 , A61P27/02 , A61P43/00 , C12N15/113 , C12Q1/00
Abstract: Methods, compounds, compositions, kits and articles of manufacture comprising anti-connexin polynucleotides for prevention and/or treatment of abnormal scars, including keloid scars, hypertrophic scars, atrophic scars, and widespread scars.
-
公开(公告)号:AU2008343756A1
公开(公告)日:2009-07-09
申请号:AU2008343756
申请日:2008-12-22
Applicant: CODA THERAPEUTICS INC
Inventor: DUFT BRADFORD J
Abstract: Compositions, articles, devices and methods for the treatment of fibrosis and fibrotic diseases, disorders, and conditions in humans and non-human animals.
-
公开(公告)号:AU2008335717A1
公开(公告)日:2009-06-18
申请号:AU2008335717
申请日:2008-12-11
Applicant: CODA THERAPEUTICS INC
Inventor: BECKER DAVID L , GREEN COLIN R , DUFT BRADFORD J
Abstract: Methods, compounds, compositions, kits and articles of manufacture comprising one or more gap junction modulating agents for treatment of wounds that do not heal at expected rates, including chronic wounds, delayed healing wounds, incompletely healing wounds, and dehiscent wounds in a subject in need thereof.
-
公开(公告)号:CA2669832A1
公开(公告)日:2008-05-22
申请号:CA2669832
申请日:2007-11-15
Applicant: CODA THERAPEUTICS INC
Inventor: DUFT BRADFORD J , GREEN COLIN R , BECKER DAVID L
IPC: A61K38/18 , A61K31/711
Abstract: Methods and compositions comprising combinations of one or more anti-conn exin agents and one or more other agents useful for the promotion and/or imp rovement of wound healing and/or tissue repair.
-
-
-
-
-
-
-
-
-